Dr. Silverman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
161 Fort Washington Ave
Fl 7
New York, NY 10032Phone+1 212-305-9770
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1994 - 1997
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1991 - 1994
- Harvard Medical SchoolClass of 1991
Certifications & Licensure
- ME State Medical License 2022 - 2026
- NY State Medical License 2024 - 2026
- RI State Medical License 2022 - 2026
- CT State Medical License 2022 - 2025
- MA State Medical License 1994 - 2025
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Treatment of Acute Lymphoblastic Leukemia in Children Start of enrollment: 2000 Sep 01
- Treatment of Acute Lymphoblastic Leukemia in Children Start of enrollment: 2005 Apr 01
- Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia Start of enrollment: 2006 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 89 citationsSecond Malignant Neoplasms After Treatment of Childhood Acute Lymphoblastic LeukemiaKjeld Schmiegelow, Mette Levinsen, Andishe Attarbaschi, André Baruchel, Meenakshi Devidas
Journal of Clinical Oncology. 2013-07-01 - 303 citationsResults of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia.Albert Moghrabi, Donna E. Levy, Barbara L. Asselin, Ronald D. Barr, Luis A. Clavell
Blood. 2007-02-01 - 2115 citationsActivating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic LeukemiaAndrew P. Weng, Adolfo A. Ferrando, Woojoong Lee, John P. Morris, Lewis B. Silverman
Science. 2004-10-08
Abstracts/Posters
- Single Cell RNA-Seq Reveals Deranged Developmental Hierarchy with Coexisting Oncogenic States and Immune Evasion Programs in ETP T-ALLLewis B. Silverman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Genetic Ancestry and Skeletal Toxicities Among Childhood Acute Lymphoblastic Leukemia Patients in the DFCI 05-001 CohortLewis B. Silverman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- New Data and Paradigms in ALL: Insights and Applications61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Enhancing Cancer Cure Quality for KidsSeptember 6th, 2024
- Dr. Lewis Silverman to Lead Pediatric Hematology, Oncology and Stem Cell Transplantation at NewYork-Presbyterian Morgan Stanley Children’s Hospital and Columbia UniversityAugust 29th, 2024
Grant Support
- Treatment Of Childhood And Adult AllNational Cancer Institute2006–2010
- Pharmacogenetics Of Asparaginase-Induced PancreatitisEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2007
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: